文献速递骨质疏松与代谢性骨病创伤骨科

2型糖尿病患者骨折后全因死亡率过度增加:一项基于人群的队列研究

Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.
PubMed 文献 · Osteoporos Int · 2017-07-25

该基于人群的队列研究利用SIDIAP数据库,纳入2006-2013年注册的≥50岁2型糖尿病患者及年龄、性别和初级保健中心匹配的无糖尿病对照,分析骨折后全因死亡率。结果显示,2型糖尿病患者骨折后全因死亡率较无糖尿病者绝对和相对均增加,调整后髋部骨折后死亡风险HR为1.28,临床椎体骨折后为1.20,任何骨折后为1.30。作者认为需进一步研究该超额风险的原因及降低骨折后病残率和死亡率的措施效果。

要点

  • 2型糖尿病患者任何骨折后全因死亡率为62.7/1000人年,无糖尿病者为49.5/1000人年。
  • 髋部骨折后死亡率最高:2型糖尿病130.7/1000人年 vs 无糖尿病112.7/1000人年。
  • 调整混杂后,2型糖尿病任何骨折后死亡风险HR 1.30(95%CI 1.23-1.37)。

核心结论

  • 2型糖尿病患者骨折后全因死亡率较无糖尿病者增加30%,绝对死亡风险超额显著。
  • 作者认为需进一步研究该超额风险的原因及降低2型糖尿病患者骨折后病残率和死亡率的措施效果。

研究设计与样本

  • 基于人群的队列研究,使用SIDIAP数据库。
  • 纳入2006-2013年注册的≥50岁2型糖尿病患者166,106例,及按年龄、性别和初级保健中心匹配的无糖尿病对照332,212例。
  • 其中分别有11,066例2型糖尿病患者和21,564例无糖尿病者发生骨折并纳入分析。
  • 随访自任何骨折、髋部骨折或临床椎体骨折之日起至死亡或删失。
  • 采用Cox回归调整年龄、性别、体质指数、吸烟、饮酒及既往缺血性心脏病和脑血管病。

主要发现

  • 骨折后死亡率(/1000人年,2型糖尿病 vs 无糖尿病):任何骨折62.7 vs 49.5,髋部骨折130.7 vs 112.7,临床椎体骨折54.9 vs 46.2。
  • 调整后任何骨折后死亡HR 1.30(95%CI 1.23-1.37),髋部骨折后HR 1.28(95%CI 1.20-1.38),临床椎体骨折后HR 1.20(95%CI 1.06-1.35),均为2型糖尿病对比无糖尿病者。

局限性

  • 作者指出需要进一步研究2型糖尿病患者骨折后超额死亡风险的原因。
  • 作者指出需要进一步研究降低2型糖尿病患者骨折后病残率和死亡率的措施效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Post-fracture mortality in type 2 diabetes mellitus (T2DM) patients has been poorly studied. We report an absolute and relative excess all-cause mortality following a fracture in these patients compared to non-diabetic patients. INTRODUCTION: T2DM and osteoporotic fractures are independently associated with a reduced lifespan, but it is unknown if T2DM confers an excess post-fracture mortality compared to non-diabetic fracture patients. We report post-fracture all-cause mortality according to T2DM status. METHODS: This is a population-based cohort study using data from the SIDIAP database. All ≥50 years old T2DM patients registered in SIDIAP in 2006-2013 and two diabetes-free controls matched on age, gender, and primary care center were selected. Study outcome was all-cause mortality following incident fractures. Participants were followed from date of any fracture (AF), hip fracture (HF), and clinical vertebral fracture (VF) until the earliest of death or censoring. Cox regression was used to calculate mortality according to T2DM status after adjustment for age, gender, body mass index, smoking, alcohol intake, and previous ischemic heart and cerebrovascular disease. RESULTS: We identified 166,106 T2DM patients and 332,212 non-diabetic, of which 11,066 and 21,564, respectively, sustained a fracture and were then included. Post-fracture mortality rates (1000 person-years) were (in T2DM vs non-diabetics) 62.7 vs 49.5 after AF, 130.7 vs 112.7 after HF, and 54.9 vs 46.2 after VF. Adjusted HR (95% CI) for post-AF, post-HF, and post-VF mortality was 1.30 (1.23-1.37), 1.28 (1.20-1.38), and 1.20 (1.06-1.35), respectively, for T2DM compared to non-diabetics. CONCLUSIONS: T2DM patients have a 30% increased post-fracture mortality compared to non-diabetics and a remarkable excess in absolute mortality risk. More research is needed on the causes underlying such excess risk, and on the effectiveness of measures to reduce post-fracture morbi-mortality in T2DM subjects.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Martinez-Laguna D, Nogues X, Abrahamsen B, et al. Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study. Osteoporos Int. 2017. PMID: 28744600. doi:10.1007/s00198-017-4096-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。